Related Experiment Video

Updated: Oct 10, 2026

Blastomere Explants to Test for Cell Fate Commitment During Embryonic Development
14:08

Blastomere Explants to Test for Cell Fate Commitment During Embryonic Development

Published on: January 26, 2013

Changes in embryonic cell fate produced by expression of an endodermal transcription factor, Xsox17

D Clements1, H R Woodland

  • 1Department of Biological Sciences, University of Warwick, CV4 7AL, Coventry, UK.

Mechanisms of Development
|November 25, 2000
PubMed

Insights

Xenopus Sox17 (Xsox17) proteins are crucial for endodermal development. Manipulating Xsox17 in embryonic cells alters their fate, causing them to become endoderm, mesoderm, ectoderm, or leading to cell death, revealing its role in cell fate determination.

Area of Science:

  • Developmental biology
  • Molecular biology
  • Xenopus embryology

Background:

  • Tissue-specific gene expression in Xenopus embryos is induced by various molecules.
  • Interfering with these molecules disrupts gene expression patterns, suggesting a role in normal development.
  • Xenopus Sox17alpha and beta (Xsox17) induce endodermal markers and are necessary for gut development.

Purpose of the Study:

  • To investigate the effect of Xsox17 manipulations on cell lineage in Xenopus embryos.
  • To determine if Xsox17 controls cell fate, including position and differentiation.

Main Methods:

  • Expressing Xsox17 in ectoderm-destined cells.
  • Disrupting Xsox17 activity in endoderm-destined cells.
  • Tracking cell lineage and fate following these manipulations.

Main Results:

  • Ectopic Xsox17 expression in ectoderm-fated cells caused their descendants to migrate into the gut or undergo late-stage cell death.
  • Disrupting Xsox17 in endoderm-fated cells resulted in their differentiation into mesodermal and ectodermal lineages.
  • These findings demonstrate a direct impact of Xsox17 on cell fate determination and lineage progression.

Conclusions:

  • Xenopus Sox17 plays a critical role in specifying endodermal cell fate.
  • Xsox17 influences cell positioning, differentiation, and survival during embryonic development.
  • The study provides evidence that Xsox17 acts as a key regulator of cell fate decisions in Xenopus embryos.

More Related Videos

Stem cell-like Xenopus Embryonic Explants to Study Early Neural Developmental Features In Vitro and In Vivo11:13

Stem cell-like Xenopus Embryonic Explants to Study Early Neural Developmental Features In Vitro and In Vivo

Published on: February 2, 2016

A Quick and Efficient Method for the Purification of Endoderm Cells Generated from Human Embryonic Stem Cells08:34

A Quick and Efficient Method for the Purification of Endoderm Cells Generated from Human Embryonic Stem Cells

Published on: March 3, 2016

Related Concept Videos

Pleiotropy01:47

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Determination01:51

Determination

During embryogenesis, cells become progressively committed to different fates through a two-step process: specification followed by determination. Specification is demonstrated by removing a segment of an early embryo, “neutrally” culturing the tissue in vitro—for example, in a petri dish with simple medium—and then observing the derivatives. If the cultured region gives rise to cell types that it would normally generate in the embryo, this means that it is specified. In contrast, determination...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.